Bridgeway Capital Management’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$466K	Hold	50,000	–	–	0.01%	834
2025 Q4	$375K	Hold	50,000	–	–	0.01%	879
2025 Q3	$435K	Buy	50,000 +25,000	+100%	+$149K	0.01%	830
2025 Q2	$92.8K	Buy	25,000 +12,516	+100%	+$44K	﹤0.01%	1082
2025 Q1	$40.3K	Buy	+12,484	New	+$58.8K	﹤0.01%	1132
2024 Q1	–	Sell	-17,400	Closed	-$353K	–	1332
2023 Q4	$353K	Sell	17,400 -10,000	-36%	-$132K	0.01%	1030
2023 Q3	$349K	Hold	27,400	–	–	0.01%	977
2023 Q2	$495K	Hold	27,400	–	–	0.01%	903
2023 Q1	$471K	Sell	27,400 -15,000	-35%	-$292K	0.01%	906
2022 Q4	$942K	Sell	42,400 -15,000	-26%	-$232K	0.02%	744
2022 Q3	$461K	Buy	+57,400	New	+$520K	0.01%	912